Ryo Koyama‐Nasu

1.3k citations
30 papers · 972 indexed · h-index 17
Topics
Immune Cell Function and Interaction (12 papers)T-cell and B-cell Immunology (9 papers)CAR-T cell therapy research (5 papers)

In The Last Decade

Ryo Koyama‐Nasu

29 papers receiving 964 citations

Peers

Ryo Koyama‐Nasu
Comparison fields: 5 of 84
  • Molecular Biology 659
  • Oncology 237
  • Immunology 213
  • Cancer Research 170
  • Genetics 73
Replace Paul‐Joseph Aspuria with:
Paul‐Joseph Aspuria United States
Ali Sadra South Korea
Alper Yetil United States
Angel A. Alvarez United States
Michael P. Holloway United States
Xavier Le Guezennec Singapore
Sarah A. Best Australia
Yeonjoo Jung South Korea
Crystal S. Conn United States
Ryo Koyama‐Nasu relative to Paul‐Joseph Aspuria United States Paul‐Joseph Aspuria's profile →
Citations per field
00.5×1.5×1.9×
Paul‐Joseph Aspuria · 1×
Citations per year

Countries citing papers authored by Ryo Koyama‐Nasu

Since Specialization
Citations

This map shows the geographic impact of Ryo Koyama‐Nasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Koyama‐Nasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Koyama‐Nasu more than expected).

Fields of papers citing papers by Ryo Koyama‐Nasu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Koyama‐Nasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Koyama‐Nasu. The network helps show where Ryo Koyama‐Nasu may publish in the future.

Co-authorship network of co-authors of Ryo Koyama‐Nasu

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Koyama‐Nasu. A scholar is included among the top collaborators of Ryo Koyama‐Nasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Koyama‐Nasu. Ryo Koyama‐Nasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 13
4 6
5 10
6 7
7 63
8 36
9 41
10 4
11 9
12 17
13 6
14 16
15 108
16 13
17 30
18 42
19 53
20 224

About Ryo Koyama‐Nasu

Ryo Koyama‐Nasu is a scholar working on Immunology, Geriatrics and Gerontology and Oncology, having authored 30 papers that have together received 972 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (9 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Cancer Research (170 citations), Immunology (213 citations) and Molecular Biology (659 citations). Ryo Koyama‐Nasu has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Michele Pagano, Daniele Guardavaccaro, David Frescas, Florian Bassermann, Toshinori Nakayama, Tetsu Akiyama, Motoko Y. Kimura, Yukiko Nasu‐Nishimura, Gregory David and Naoko Tanese. Their work appears in journals such as Nature, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026